BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

The study explored factors influencing cancer pharmacists’ progression through consultant-level credentialing and examined the impact of the BOPA Cancer Consultant Pharmacist Credentialing Webinar Series.

The findings identified several common barriers to credentialing, including time constraints, limited organisational support and lack of mentorship. Importantly, pharmacists who attended the BOPA webinar series were more likely to report progression with their credentialing portfolio than those who did not attend.

These findings reinforce the value of providing structured support, peer networking and practical guidance to pharmacists undertaking advanced and consultant credentialing.

Read the article here:
https://academic.oup.com/ijpp/advance-article-abstract/doi/10.1093/ijpp/riag073/8704625

Continue your credentialing journey with us at our next Cancer Advanced and Consultant Pharmacist Credentialing Support Series webinar:

Date: Thursday 18 June 2026
Time: 13:00–14:00
Topic: Research Domain

Speakers:
• Nick Duncan – Consultant Pharmacist
• Dr Melanie Dalby – Clinical Academic Research Lead
• Tiffany Chan – Lead Pharmacist Cancer Services

The webinar is open to BOPA paid members who are undertaking or considering Advanced or Consultant Pharmacist credentialing.

Further information:
https://www.bopa.org.uk/credentialing-support-series/

Thank you to everyone who has contributed to and supported this important initiative.

Best wishes,

BOPA Education & Training Subcommittee

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article